These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8185524)

  • 21. [Focal hemorrhagic chorioretinopathy. Clinical differentiation and visual prognosis].
    Pauleikhoff D; Schrenk M; Schilling H; Knebel C; Peuser M; Nalik H; Wessing A
    Ophthalmologe; 1994 Jun; 91(3):306-11. PubMed ID: 8086745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes.
    Sickenberg M; Schmidt-Erfurth U; Miller JW; Pournaras CJ; Zografos L; Piguet B; Donati G; Laqua H; Barbazetto I; Gragoudas ES; Lane AM; Birngruber R; van den Bergh H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
    Arch Ophthalmol; 2000 Mar; 118(3):327-36. PubMed ID: 10721954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results.
    Hudson HL; Lane SS; Heier JS; Stulting RD; Singerman L; Lichter PR; Sternberg P; Chang DF;
    Ophthalmology; 2006 Nov; 113(11):1987-2001. PubMed ID: 16989902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New and classic insights into presumed ocular histoplasmosis syndrome and its treatment.
    Oliver A; Ciulla TA; Comer GM
    Curr Opin Ophthalmol; 2005 Jun; 16(3):160-5. PubMed ID: 15870572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to ocular histoplasmosis syndrome.
    Nielsen JS; Fick TA; Saggau DD; Barnes CH
    Retina; 2012 Mar; 32(3):468-72. PubMed ID: 21817958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1994 Apr; 112(4):500-9. PubMed ID: 7512336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of minimum clinically meaningful changes in scores on the National Eye Institute Visual Function Questionnaire (NEI-VFQ) SST Report Number 19.
    Submacular Surgery Trials Research Group
    Ophthalmic Epidemiol; 2007; 14(4):205-15. PubMed ID: 17896299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presumed ocular histoplasmosis syndrome in India.
    Sinha R; Raju S; Garg SP; Venkatesh P; Talwar D
    Ocul Immunol Inflamm; 2007; 15(4):315-7. PubMed ID: 17763129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. INTRAVITREAL AFLIBERCEPT INJECTION FOR CHOROIDAL NEOVASCULARIZATION DUE TO PRESUMED OCULAR HISTOPLASMOSIS SYNDROME: The HANDLE Study.
    Toussaint BW; Kitchens JW; Marcus DM; Miller DM; Kingdon ML; Holcomb D; Ivey K
    Retina; 2018 Apr; 38(4):755-763. PubMed ID: 28333879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of outcomes for intravitreal bevacizumab in the treatment of choroidal neovascularization secondary to ocular histoplasmosis.
    Cionni DA; Lewis SA; Petersen MR; Foster RE; Riemann CD; Sisk RA; Hutchins RK; Miller DM
    Ophthalmology; 2012 Feb; 119(2):327-32. PubMed ID: 22133795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aetiological study of the presumed ocular histoplasmosis syndrome in the Netherlands.
    Ongkosuwito JV; Kortbeek LM; Van der Lelij A; Molicka E; Kijlstra A; de Smet MD; Suttorp-Schulten MS
    Br J Ophthalmol; 1999 May; 83(5):535-9. PubMed ID: 10216050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical removal of subfoveal neovascularization in the presumed ocular histoplasmosis syndrome.
    Thomas MA; Kaplan HJ
    Am J Ophthalmol; 1991 Jan; 111(1):1-7. PubMed ID: 1985467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corticosteroids as an antiangiogenic agent for histoplasmosis-related subfoveal choroidal neovascularization.
    Martidis A; Miller DG; Ciulla TA; Danis RP; Moorthy RS
    J Ocul Pharmacol Ther; 1999 Oct; 15(5):425-8. PubMed ID: 10530703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of blindness and low vision in a sample population: the Priverno Eye Study, Italy.
    Cedrone C; Culasso F; Cesareo M; Nucci C; Palma S; Mancino R; Cerulli L
    Ophthalmology; 2003 Mar; 110(3):584-8. PubMed ID: 12623826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The syndrome of presumed ocular histoplasmosis in Mexico: a preliminary study.
    Pedroza-Seres M; Quiroz-Mercado H; Granados J; Taylor ML
    J Med Vet Mycol; 1994; 32(2):83-92. PubMed ID: 8064547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevalence of HLA-B7 in presumed ocular histoplasmosis in patients with peripheral atrophic scars.
    Meredith TA; Smith RE; Braley RE; Witkowski JA; Koethe SM
    Am J Ophthalmol; 1978 Sep; 86(3):325-8. PubMed ID: 717495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presumed ocular histoplasmosis in The Netherlands--an area without histoplasmosis.
    Suttorp-Schulten MS; Bollemeijer JG; Bos PJ; Rothova A
    Br J Ophthalmol; 1997 Jan; 81(1):7-11. PubMed ID: 9135400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Argon green vs krypton red laser photocoagulation for extrafoveal choroidal neovascularization. One-year results in ocular histoplasmosis. The Canadian Ophthalmology Study Group.
    Arch Ophthalmol; 1994 Sep; 112(9):1166-73. PubMed ID: 7522003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal bevacizumab for choroidal neovascularization in ocular histoplasmosis.
    Schadlu R; Blinder KJ; Shah GK; Holekamp NM; Thomas MA; Grand MG; Engelbrecht NE; Apte RS; Joseph DP; Prasad AG; Smith BT; Sheybani A
    Am J Ophthalmol; 2008 May; 145(5):875-8. PubMed ID: 18321466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C.
    Kashiwagi K; Kogure S; Mabuchi F; Chiba T; Yamamoto T; Kuwayama Y; Araie M;
    Acta Ophthalmol; 2016 Nov; 94(7):e561-e570. PubMed ID: 27156361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.